You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Claims for Patent: 11,975,013

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 11,975,013

Title:	Stable formulations comprising thiotepa
Abstract:	The present disclosure provides pharmaceutical compositions comprising thiotepa and one selected from PEG, such as PEG400 or PEG600, and DMSO, and optionally water or an aqueous saline solution and thiosulfate. The composition is free or substantially free of impurities. Also provided is a method for treating cancer in a subject, or myeloablation prior to bone marrow transplantation using the composition. A method for enhancing the stability of a thiotepa formulation is also contemplated.
Inventor(s):	Sharon Cunningham, Orlaith RYAN, Johannes Jan Platteeuw
Assignee:	Shorla Pharma Ltd
Application Number:	US17/901,284
Patent Claims:	1. A composition comprising thiotepa and a solvent, wherein the solvent is selected from the group consisting of dimethylsulfoxide (DMSO), polyethylene glycol 400 (PEG400), polyethylene glycol 600 (PEG600), dimethylacetamide (DMA), and N-methylpyrrolidone (NMP), and wherein the thiotepa is present in an amount between about 1 and about 100 mg/mL, wherein the composition is substantially free of impurities, and wherein the impurities are formic acid, acetic acid, formaldehyde, acetaldehyde, and peroxide and the amount of the impurities are: less than about 150 ppm formic acid; less than about 15 ppm acetic acid; less than about 15 ppm formaldehyde; less than about 15 ppm acetaldehyde; and less than about 35 ppm peroxide . 2. The composition of claim 1, wherein the composition does not comprise water. 3. The composition of claim 1, wherein the composition comprises thiotepa and PEG400. 4. The composition of claim 1, wherein the composition comprises thiotepa and PEG600. 5. The composition of claim 1, wherein the composition comprises thiotepa and DMSO. 6. The composition of claim 1, wherein the composition further comprises water. 7. The composition of claim 6, wherein the water is present in an amount selected from the group consisting of up to about 30%, up to about 25%, up to about 20%, up to about 15%, up to about 10%, and up to about 5%. 8. The composition of claim 6, wherein the composition comprises thiotepa and PEG400. 9. The composition of claim 6, wherein the composition comprises thiotepa and PEG600. 10. The composition of claim 6, wherein the composition comprises thiotepa and DMSO. 11. The composition of claim 6, wherein the water is an aqueous saline solution. 12. The composition of claim 1, further comprising thiosulfate. 13. The composition of claim 12, wherein the thiosulfate is present in an amount of about 0.01% to about 1.0%.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.